Over the years, changes occur in our bodies. Already at the age of 30-35 years, the activity of biological processes begins to decrease, the amount of necessary vitamins and microelements gradually decreases, aging processes are activated in cells. There are also changes in the eyes, for example, the concentration of EPA and DHA Omega-3 fatty acids in the retina begins to decrease, so the sensitivity of our eyes to light decreases, and we begin to see worse at dusk, color vision becomes weaker(1; 2).

The rate of age-related changes in a person’s appearance and the age of the internal organs depends on many factors, including physical activity, emotional state, and eating habits. Therefore, we can influence the activity of the aging process by maintaining a healthy lifestyle and providing our bodies with the necessary nutrients. In addition, with age, our protective antioxidant systems become increasingly difficult to deal with harmful factors – metabolic products and external damaging factors. Therefore, antioxidant supplements with age become simply necessary for us.

Premium Asta Omega 3® for vision improvement

Due to different investigations, the natural supplement Premium Asta Omega 3® can be recommended as a clean sustainable source of EPA, DHA, and antioxidants for the whole family.  In Premium Asta Omega 3® EPA and DHA with Alpha-Tocopherol (Vitamin E) are mixed for better cell protection and filled up with natural lemon flavor to destroy the fishy taste. Also, producers added Astaxanthin, a red-colored xanthophyll carotenoid, that exerts an anti-oxidative and anti-inflammatory effect on various cell lines.

What is Omega-3?

Omega-3 polyunsaturated fatty acids (EPA and DHA) are important fats needed to maintain vision and overall health. They are not produced by the body, their functions can not take over any other substances. Therefore, they are considered indispensable.

Omega-3 acids play a huge role in the proper functioning of the body. Because EPA and DHA are important components of cell membranes, they have a significant impact on what a cell will excrete and what it will absorb. Thus, omega-3 fatty acids are important for brain development and function, cognitive abilities, preventing age-related decline in mental abilities, and supporting the maintenance of normal visual function (3).

High concentrations of omega-3 fatty acids are found in the brain and the light-sensitive layer of the retina (macula). This layer is also called visual, or macular, pigment. So, high levels of omega-3 fatty acids in the body are known to be a powerful factor in maintaining healthy eyesight (4). Today we know the main mechanisms by which they have such an impact, namely:

With Premium Asta Omega 3® we get 2750 mg highly bioavailable Omega 3 fatty acids per tablespoon!

What is Astaxanthin?

Another important component of Premium Asta Omega 3® is Astaxanthin, a red-colored xanthophyll carotenoid, that has a strong antioxidant capacity. Owing to its antioxidant ability and cell signal modulating properties, Astaxanthin exhibits a variety of beneficial biological activities and effects (5). These include protection against UV damage, anti-inflammatory and immunomodulatory activity, alleviation of metabolic syndrome, cardioprotective effects, anti-diabetic activity, prevention of neuronal damage, anti-aging, and anti-cancer activity, as well as inhibition of cell membrane peroxidation.

There is increasing evidence that antioxidant carotenoids are extremely important to your eye health (6). Studies show that astaxanthin can potentially:

Thus, Omega-3 fatty acids and antioxidants play an important role in maintaining vision. It was shown that in people who take Omega-3 for a long time, the concentration of DHA in the retina increases, thereby increasing the sensitivity of the eye to light (1; 2) and maintaining normal vision. Therefore, taking care of your eyes, you should include in your daily diet a natural effective supplement Premium Asta Omega 3®. This unique formula of 2750 mg Omega fatty acids, Vitamin E mixture, and Natural Astaxanthin from microalgae is essential for health and life quality. It consists of 100% pure triglycerides, has no oxidized oils, is free of heavy metals, toxins, and GMOs, and has approved quality.

Of course, it seems to us that at 30-35 we are still young and age-related eye diseases are still very far away, but by improving nutrition, we can get rid of them all together! This world is colorful, we must see it!

Dr. Oksana Klymenko MD., PhD, 
Medical Doctor, Researcher in the fields of molecular physiology 
and pathophysiology, molecular biology, genetics, cell biology

Reference

  1. Dangour A.D., Clemens F., Elbourne D. et al, 2006, A randomized controlled trial investigating the effect of n-3 long-chain polyunsaturated fatty acid supplementation on cognitive and retinal function in cognitively healthy older people: the Older People And n-3 long-chain polyunsaturated fatty acids (OPAL) study protocol [ISRCTN72331636], Nutrition Journal
  2. Stough C. et al., 2011, The effects of 90-day supplementation with the Omega-3 essential fatty acid docosahexaenoic acid (DHA) on cognitive function and visual acuity in a healthy aging population, Elsevier, Neurobiology of Aging, Vol 33, Issue 4, 824.e1–824.e3
  3. Schwalfenberg G. Omega-3 fatty acids: their beneficial role in cardiovascular health [published correction appears in Can Fam Physician. 2006 Aug;52:952]. Can Fam Physician. 2006;52(6):734-740.
  4. Zhang AC, Singh S, Craig JP, Downie LE. Omega-3 Fatty Acids and Eye Health: Opinions and Self-Reported Practice Behaviors of Optometrists in Australia and New Zealand. Nutrients. 2020;12(4):1179. Published 2020 Apr 22. doi:10.3390/nu12041179
  5. Kim, Suhn & Kim, Hyeyoung. (2018). Inhibitory Effect of Astaxanthin on Oxidative Stress-Induced Mitochondrial Dysfunction-A Mini-Review. Nutrients. 10. 1137. 10.3390/nu10091137.
  6. 6. Giannaccare G, Pellegrini M, Senni C, Bernabei F, Scorcia V, Cicero AFG. Clinical Applications of Astaxanthin in the Treatment of Ocular Diseases: Emerging Insights. Mar Drugs. 2020;18(5):239. Published 2020 May 1. doi:10.3390/md18050239

 

Leave a Reply

Your email address will not be published. Required fields are marked *

error: Content is protected !!